Analysis of NLR, HDL, and Hs-Troponin I as A Diagnostic Marker in STEMI and NSTEMI Patients
DOI:
https://doi.org/10.24293/ijcpml.v29i1.2083Abstract
The limitations of health facilities in diagnosing AMI, especially in remote areas require an easy and inexpensive examination such as Neutrophil Lymphocyte Ratio (NLR) and High-Density Lipoprotein (HDL), which have a positive correlation with hs-Troponin I. The purpose of this study was to analyze the value of NLR, HDL, and hs-Troponin I as diagnostic markers in STEMI and NSTEMI patients. This retrospective study used medical record data for 152 STEMI patients and 93 NSTEMI patients from January to December 2020 at Dr. Wahidin Sudirohusodo. The NLR value was based on the results of routine blood tests using Sysmex XN-10, the results of HDL examinations using the Bio Majesty JCA-BM9010/c instrument, and the results of the hs-Troponin I examination using the Vidas instrument. Statistical tests using the MannWhitney test, the diagnostic value of NLR, and hs-Troponin I was analyzed by ROC to obtain the cut-off. The test result is significant if p <0.05. The sample consisted of 152 samples of STEMI patients and 93 NSTEMI patients. The NLR value in STEMI patients was significantly different from NSTEMI patients (p <0.001), HDL levels were not significantly different in STEMI and NSTEMI patients (p=0.475), while hs-Troponin I levels were significantly higher in STEMI patients than NSTEMI (p <0.001). The ROC curve showed the sensitivity and specificity of NLR, namely 64% and 70% at the cut-off of 4.32, and the sensitivity and specificity of hs-Troponin I was 78% and 60% at the cut-off of 910.5 ng /L. The NLR and hs-Troponin I values was increased in STEMI patients compared to NSTEMI due to the increased inflammatory response and the higher risk of damage to the myocardium. The coordinates of the NLR ROC curve show a cut-off of 4.32 and hs-Troponin I 910.5 ng/L provides optimal sensitivity and specificity. The conclusion of this study is NLR and hs-Troponin I can be used as diagnostic markers in STEMI and NTEMI patients with a cut-off value of NLR 4.32 and hs-Troponin I 910.5 ng/L.Downloads
References
Irmalita, Juzar D, Andrianto, Setianto B, Tobing D, et al. Pedoman tatalaksana SKA PERKI 2015. Indonesian Heart Association, 2015; 21–24.
Kumar A, Cannon CP. Acute coronary syndromes: Diagnosis and management, part I. Mayo Clinic Proceeding, 2019; 84(10): 917–938.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, et al. 2020 AHA/ACC guideline for the
management of patients with non-ST-elevation acute coronary syndromes: Executive summary. Circulation, 2020; 130: 2354-2394.
World Health Organization. 2018. The top 10 causes of death. Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed
March 24, 2021).
Benjamin EJ, Blaha MJ, Chiuve SE, Cruhman M, Das SR, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation, 2017; 35(10): e146-e603.
Riset Kesehatan Dasar (Riskesdas). Jakarta, Badan Litbankes Depkes RI, 2018; 147.
Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB. Novel biomarkers for cardiovascular risk prediction. Journal of Geriatric Cardiology, 2017; 14(2): 135.
Tahhan AS, Sandesara P, Hayek SS, Hammadah M, Alkhoder A, et al. High-sensitivity Troponin I levels and coronary artery disease severity, progression, and long-term outcomes. J Am Heart Assoc, 2018; 7(5): 1-11.
Retnoningrum D, Widyastiti NC, Jaludamascena A. Hubungan antara Neutrophil/Lymphocyte Ratio
(NLR) dan High-Density Lipoprotein (HDL) pada sindrom koroner akut. Media Medika Muda, 2017; 2(2): 131-135.
Schaffer A, Verdoia M, Barbieri L, Aprami TM, Suryapranata H, et al. High-density lipoproteins and
coronary artery disease: A single-center cohort study. Angiology, 2018; 65(8): 696–702.
Tok D, Iscen S, Ozenc S. Neutrophil–lymphocyte ratio is associated with low high-density lipoprotein
cholesterol in healthy young men. SAGE Open Med, 2018; 2(X): 2014–6.
Prajapati JH, Sahoo S, Nikam T, Shah KH, Maheriya B, Parmar M. Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients. J Lipids, 2015; 1–8.
Sonmez O, Ertas G, Bacaksiz A, Tasal A, Erdogan E, et al. Relation of neutrophil to lymphocyte ratio with the presence and complexity of coronary artery disease: An observational study. Anadolu Kardiyol Derg, 2015; 13(7): 662-7.
Munir TA, Afzal MN. Assessment of differential leukocyte count in patients with acute coronary syndrome. JPMA, 2016; 60(7): 548-51.
Zazula AD, Precoma-Neto D, Gomes AM, Kruklis H, Barbieri GF, et al. An assessment of neutrophils/
lymphocytes ratio in patients suspected of acute coronary syndrome. Arq Bras Cardiol, 2018; 90(1): 30-5.
Selcuk H, Dinc L, Selcuk MT, Maden O, Temizhan A. The relation between differential leukocyte count,
neutrophil to lymphocyte ratio and presence and severity of coronary artery disease. Open Journal of
Internal Medicine, 2019; 2: 163-9.
Ozturk S, Erdem A, Ozlu MF, Ayhan S, Erdem K, et al. Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Arch Turk Soc Cardiol, 2015; 41: 284-9.
Ema Tahto, Radivoj Jadric, Lamija Pojskic, Esmeralda Kicic. Neutrophyl-to-lumphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome. Med Arch, 2017; 71(5): 312-315.
Bajari R, Tak S. Predictive prognostic value of neutrophil–lymphocytes ratio in acute coronary syndrome. Indian Heart Journal, 2017; 69: S46-S50.
Altun B, Turkon H, Tasolar H, Beggi H, Altun M, et al. The relationship between high-sensitive Troponin T, neutrophil lymphocyte ratio and SYNTAX score. Scandinavian Journal of Clinical and Laboratory Investigation, 2014; 74: 108-115.
Annema W, Willemsen HM, Boer JF, Dikkers A, Giet MV, et al. HDL function in impaired in acute
myocardian infarction independent of plasma HDL cholesterol levels. Journal of Lipidology, 2016; 1-11.
Kosmas CE, Martinez I, Sourlas A, Bouza KV, Campos FN, et al. High-Density Lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context, 2018; V.7: 1–9.
Vasile VC, Jaffe AS. High-sensitivity cardiac Troponin in evaluation of possible AMI. American College of Cardiology, 2018; 1-12.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
